You are here

Article Text

Article menu
Download PDFPDF
Neurological web
Antiepileptic drug withdrawal risk calculator
  1. Francesco Brigo1,2
  1. 1 Department of Neuroscience, Biomedicine and Movement Science, University of Verona, Verona, Italy
  2. 2 Department of Neurology, Franz Tappeiner Hospital, Merano, Italy
  1. Correspondence to Dr Francesco Brigo, Department of Neuroscience, Biomedicine and Movement, University of Verona, Piazzale L.A. Scuro, 10 - 37134 Verona, Italy; dr.francescobrigo{at}gmail.com

https://doi.org/10.1136/practneurol-2017-001715

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    It is often challenging to predict the risk of seizure recurrence after withdrawal of antiepileptic medication in people with epilepsy who are currently seizure free. One can obtain a quantified estimate of such risk using the ‘prognostic index for recurrence of seizures within one and two years after continuing antiepileptic drug treatment or starting slow withdrawal,’ derived from results of the 1991 ‘Medical Research Council study for antiepileptic drug withdrawal.’1 Until recently I would manually enter all information required by this prognostic index into a Microsoft Excel table …

    View Full Text

    Footnotes

    • Contributors FB conceived and wrote this article.

    • Competing interests FB has received speaker honoraria from Eisai and PeerVoice, payment for consultancy from Eisai, and travel support from Eisai, ITALFARMACO and UCB Pharma.

    • Provenance and peer review Not commissioned; internally peer reviewed.

    Linked Articles

    • Editors' commentary
      Highlights of the issue
      Phil E M Smith Geraint N Fuller
      Practical Neurology 2017; 17 249-249 Published Online First: 13 Jul 2017. doi: 10.1136/practneurol-2017-001712

    Other content recommended for you